In a major step toward closing the final “loopholes” in US antimicrobial stewardship, the FDA Center for Veterinary Medicine (CVM) officially finalized Guidance for Industry (GFI) #273 on May 14, 2026. This directive tackles a decades-old issue in the livestock industry: the use of medically important antibiotics in animal feed without defined end dates.
The Core Directive: Ending “Continuous Use”
Historically, many antibiotics approved in the 1960s and 70s—such as certain macrolides and tetracyclines—were labelled for “continuous use” or lacked a specific duration limit. GFI #273 requires drug sponsors to revise these labels to ensure every medically important antimicrobial has:
- A defined duration of use: No more “feed until market weight” or open-ended instructions.
- Targeted clinical windows: Labels must now specify the exact number of days (e.g., “Feed for 7–14 days”) based on the period of clinical risk.
- Veterinary justification: Precise durations allow veterinarians to better align their prescriptions with the actual disease pressure on the farm.
Impact by the Numbers
The FDA has identified over 100 affected products currently used in the cattle, swine, and poultry sectors.
- 30%: The estimated percentage of medically important feed-grade antibiotics that currently lack a defined duration.
- 3 Years: The timeline given to pharmaceutical sponsors to complete label revisions and submit supplemental New Animal Drug Applications (NADAs).
Sector Spotlight: The “Tylosin” Transition
One of the most significant impacts will be on the use of Tylosin for preventing liver abscesses in feedlot cattle. Previously used continuously for over 100 days in some protocols, this drug—which is closely related to human macrolides—will now face strict duration caps.
Industry Reaction: A Mixed Bag
The response from the animal health community has been polarized:
- Public Health Advocates: While welcoming the change, groups like the Food Animal Concerns Trust (FACT) argue the guidance is “too little, too late,” noting that it is non-binding and allows industry sponsors to set their own limits based on production needs rather than strict public health caps (such as a 21-day default limit).
- Producer Groups: Organizations representing cattle and swine producers expressed concerns over the “loss of flexibility” in managing chronic disease pressures, particularly in large-scale operations where individual animal treatment is physically impossible.
- Veterinary Response: The AVMA has largely supported the move, emphasizing that it reinforces the Veterinary Feed Directive (VFD) by giving practitioners the regulatory “teeth” needed to limit long-term antibiotic exposure.
AHI Analysis: Why This Matters Now
This isn’t just about paperwork; it’s about the “Last Mile” of stewardship. By removing “continuous use” from labels, the FDA is effectively making long-term preventive feeding a violation of federal law. For the animal health industry, this will likely drive a massive surge in demand for vaccines, probiotics, and precision diagnostic tools as producers seek legal alternatives to maintain herd health without relying on the “safety net” of constant antibiotic inclusion.
